Compare AU
Compare BNDS vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Westn Asset Aus Bond Fund (Managed Fund) (BNDS) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
BNDS | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 13 | 61 |
Median incremental investment | $707.68 | $920.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $916.50 | $1,892.10 |
Average age group | > 35 | 26 - 35 |
Key Summary
BNDS | DRUG | |
|---|---|---|
Strategy | BNDS.AX was created on 2018-11-07 by BetaShares. The fund's investment portfolio concentrates primarily on broad credit fixed income. The Fund aims to earn an after fee return in excess of the Bloomberg AusBond Composite 0+yr Index over rolling three year periods. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | AUSTRALIAN GOVERNMENT 2.75% MAY-41 (2.26 %) AUSTRALIAN GOVERNMENT 3.5% DEC-34 (1.63 %) AUSTRALIAN GOVERNMENT 3.75% MAY-34 (1.61 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (99.56 %) Communication Services (0.44 %) | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.42 % | 0.57 % |
Key Summary
BNDS | DRUG | |
|---|---|---|
Issuer | BetaShares | BetaShares |
Tracking index | Bloomberg AusBond Composite Index - AUD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.42 % | 0.57 % |
Price | $23.50 | $7.95 |
Size | $786.559 million | $185.172 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 2.44 % | 1.90 % |
Market | ASX | ASX |
First listed date | 16/11/2018 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
BNDS | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 13 | 61 |
Median incremental investment | $707.68 | $920.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $916.50 | $1,892.10 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
BNDS | DRUG | |
|---|---|---|
Pros |
|
|
Cons |
|
|
BNDS | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |